• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Financestock exchanges

Global markets rise as investors bet Trump’s tariffs on the tech supply chain won’t happen

Jim Edwards
By
Jim Edwards
Jim Edwards
Executive Editor, Global News
Jim Edwards
By
Jim Edwards
Jim Edwards
Executive Editor, Global News
April 14, 2025, 6:12 AM ET
Tim Cook
Apple CEO Tim Cook at the opening of Apple's first retail store in India, in Mumbai on April 18, 2023. (Photo: Punit Paranjpe/AFP/Getty Images)
  • Global markets rose this morning on news that President Trump’s impending tariffs on tech products would be exempted or delayed. However, there remains confusion over whether and when the White House will act against the smartphone, semiconductor, and device supply chain. 

Today, investors in the U.S. markets will be grappling with the question of whether they believe Trump will impose steep tariffs on Big Tech’s China supply chain (as he said he would on Sunday) or whether he will back off (as the the U.S. Customs and Border Protection said it would on Friday). 

Recommended Video

Right now, stocks are trading up, so investors think the tech tariffs are at least being pushed off into the future or won’t happen at all. 

Apple stock was boosted 5.45% in overnight trading and hit $208.95 this morning, premarket. Most of the company’s supply chain is trapped behind Trump’s tariff barriers on China and it would thus benefit if the tariffs end up not happening.

Here’s a snapshot from Fortune’s CEO Daily of where markets stood in early trading before the opening bell in New York:

  • UK’s FTSE 100 was up 1.9% in early trading.
  • The Euro Stoxx 600 was up strongly by 2.3% this morning. 
  • Japan’s Nikkei was up 1.2%.
  • Hong Kong’s Hang Seng was up 2.4%.
  • China’s SSE Composite was up 0.76%.
  • The VIX fear index has fallen by 30% over the last five days. 
  • The S&P 500 closed up 1.8% on Friday and futures contracts for the index were trading up a further 1.5% this morning, premarket.

The U.S. may be in a weaker position in the China trade war than the president thinks, according to a Goldman Sachs note sent to clients yesterday, from analysts Andrew Tilton et al.

That’s because the U.S. is more dependent on imports from China than China is dependent on imports from the U.S., they say: “Our findings reveal that US reliance on Chinese imports is far greater than China’s reliance on US imports. For 36% of US imports from China (around $158 billion), the US depends on China for over 70% of its supply, indicating limited short-term flexibility for American importers to find alternative sources, even under substantial tariff pressures.

“In contrast, China’s reliance on US imports above the 70% threshold totals just $14 billion, while more than half of China’s imports from the US fall into categories where the US supplies less than 30% of China’s total demand.

“Within high-dependence categories (e.g., over 70% reliance), the US shows concentrated exposure to Chinese-made final consumer goods, particularly communication equipment (e.g., telephones, representing 9% of total U.S. imports from China) and toys (2.5%). Meanwhile, only 10% of China’s imports from the U.S. exceed the 70% reliance threshold, nearly all of which are transportation-related—primarily aircraft and spacecraft,” the note said.

Fortune Brainstorm AI returns to San Francisco Dec. 8–9 to convene the smartest people we know—technologists, entrepreneurs, Fortune Global 500 executives, investors, policymakers, and the brilliant minds in between—to explore and interrogate the most pressing questions about AI at another pivotal moment. Register here.
About the Author
Jim Edwards
By Jim EdwardsExecutive Editor, Global News
LinkedIn iconTwitter icon

Jim Edwards is the executive editor for global news at Fortune. He was previously the editor-in-chief of Business Insider's news division and the founding editor of Business Insider UK. His investigative journalism has changed the law in two U.S. federal districts and two states. The U.S. Supreme Court cited his work on the death penalty in the concurrence to Baze v. Rees, the ruling on whether lethal injection is cruel or unusual. He also won the Neal award for an investigation of bribes and kickbacks on Madison Avenue.

See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.